Corient Private Wealth LLC Cuts Stock Position in DaVita Inc. (NYSE:DVA)

Corient Private Wealth LLC cut its position in DaVita Inc. (NYSE:DVA) by 5.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,844 shares of the company’s stock after selling 2,075 shares during the quarter. Corient Private Wealth LLC’s holdings in DaVita were worth $5,211,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in DVA. SBI Securities Co. Ltd. bought a new stake in shares of DaVita in the fourth quarter valued at $41,000. Quarry LP bought a new stake in shares of DaVita during the 3rd quarter valued at $60,000. Venturi Wealth Management LLC raised its stake in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc raised its stake in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. raised its stake in shares of DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after purchasing an additional 131 shares during the period. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Performance

NYSE:DVA opened at $148.25 on Friday. The business’s 50-day moving average price is $158.53 and its two-hundred day moving average price is $157.48. DaVita Inc. has a twelve month low of $125.64 and a twelve month high of $179.60. The stock has a market cap of $11.86 billion, a P/E ratio of 13.80, a PEG ratio of 1.07 and a beta of 0.99. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DVA. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research note on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Finally, StockNews.com lowered DaVita from a “buy” rating to a “hold” rating in a research note on Friday. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, DaVita presently has an average rating of “Hold” and an average price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.